Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., M.C.P.S, F.C.P.S.
Diabetologist
M.B.B.S, P.G Diabetes, M.Sc Diabetes
Infectious Disease Specialist
M.B.B.S., F.C.P.S., F.C.P.S.
Gastroenterologist
MBBS, FCPS, MRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
General Physician
MBBS, MCPS
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Diabetologist
M.B.B.S., M.M.C.H (Pediatrics), PGD Nutrition, Dip. in Diabetes (DMC)
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Gastroenterologist
M.B.B.S., F.C.P.S., MACG (America), Certification Harward Medical School (America ), Certification Royal College of Physician(UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures